Cargando…

Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study

BACKGROUND: trans-fatty acids (TFAs) are a well-known risk factor of ischemic heart disease (IHD). In Australia, the highest TFA intake is concentrated to the most socioeconomically disadvantaged groups. Elimination of industrial TFA (iTFA) from the Australian food supply could result in reduced IHD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marklund, Matti, Zheng, Miaobing, Veerman, J. Lennert, Wu, Jason H. Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605626/ https://www.ncbi.nlm.nih.gov/pubmed/33137090 http://dx.doi.org/10.1371/journal.pmed.1003407

Ejemplares similares

Estimated health benefits, costs and cost-effectiveness of eliminating dietary industrial trans fatty acids in Kenya: cost-effectiveness analysis
por: Marklund, Matti, et al.
Publicado: (2023)

Contribution of Trans-Fatty Acid Intake to Coronary Heart Disease Burden in Australia: A Modelling Study
por: Wu, Jason H. Y., et al.
Publicado: (2017)

Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs
por: Rubinstein, Adolfo, et al.
Publicado: (2015)

Health services costs for cancer care in Australia: Estimates from the 45 and Up Study
por: Goldsbury, David E., et al.
Publicado: (2018)

The Impact of Policies to Reduce trans Fat Consumption: A Systematic Review of the Evidence
por: Downs, Shauna M, et al.
Publicado: (2017)

The Cost-Effectiveness of Laparoscopic Adjustable Gastric Banding in the Morbidly Obese Adult Population of Australia
por: Lee, Yong Yi, et al.
Publicado: (2013)

Taxes and Subsidies for Improving Diet and Population Health in Australia: A Cost-Effectiveness Modelling Study
por: Cobiac, Linda J., et al.
Publicado: (2017)

Health services costs for lung cancer care in Australia: Estimates from the 45 and Up Study
por: Goldsbury, David E., et al.
Publicado: (2020)

Indirect costs of depression and other mental and behavioural disorders for Australia from 2015 to 2030
por: Schofield, Deborah, et al.
Publicado: (2019)

Modelled health benefits of a sugar-sweetened beverage tax across different socioeconomic groups in Australia: A cost-effectiveness and equity analysis
por: Lal, Anita, et al.
Publicado: (2017)

Evaluating progress and addressing actions to eliminate industrially produced trans-fatty acids in the Americas
por: Rincón-Gallardo, Patiño Sofía, et al.
Publicado: (2022)

Correction: Modelled health benefits of a sugar-sweetened beverage tax across different socioeconomic groups in Australia: A cost-effectiveness and equity analysis
por: Lal, Anita, et al.
Publicado: (2020)

A cost–benefit analysis framework for preventive health interventions to aid decision-making in Australian governments
por: Ananthapavan, Jaithri, et al.
Publicado: (2021)

Understanding the Complexities of Eliminating Trans Fatty Acids: The Case of the Trans Fatty Acid Ban in Thailand
por: Samsiripong, Weerapak, et al.
Publicado: (2022)

Cost-Effectiveness of Pharmacotherapy to Reduce Obesity
por: Veerman, J. Lennert, et al.
Publicado: (2011)

Cost-Effectiveness of Interventions to Promote Fruit and Vegetable Consumption
por: Cobiac, Linda J., et al.
Publicado: (2010)

Influence of Heating during Cooking on Trans Fatty Acid Content of Edible Oils: A Systematic Review and Meta-Analysis
por: Bhat, Saiuj, et al.
Publicado: (2022)

The indirect costs of ischemic heart disease through lost productive life years for Australia from 2015 to 2030: results from a microsimulation model
por: Schofield, Deborah, et al.
Publicado: (2019)

Hepatitis C elimination in Myanmar: Modelling the impact, cost, cost-effectiveness and economic benefits
por: Scott, Nick, et al.
Publicado: (2021)

Priority-setting for obesity prevention—The Assessing Cost-Effectiveness of obesity prevention policies in Australia (ACE-Obesity Policy) study
por: Ananthapavan, Jaithri, et al.
Publicado: (2020)

ELIMINATION OF INDUSTRIALIZED TRANS-FATTY ACIDS FROM NIGERIAN MEALS – AN URGENT NEED FOR POLICY ADOPTION, IMPLEMENTATION, AND PUBLIC EDUCATION
por: Fagbule, O.F.
Publicado: (2021)

Cost-Effectiveness of Preventive Interventions to Reduce Alcohol Consumption in Denmark
por: Holm, Astrid Ledgaard, et al.
Publicado: (2014)

Estimating and costing for the metal manufacturing industries
por: Creese, Robert C, et al.
Publicado: (1992)

Estimated Impact of Achieving the Australian National Sodium Reduction Targets on Blood Pressure, Chronic Kidney Disease Burden and Healthcare Costs: A Modelling Study
por: Aminde, Leopold Ndemnge, et al.
Publicado: (2023)

Cost assessment of a program for laboratory testing of plasma trans-fatty acids in Thailand
por: Datta, Biplab Kumar, et al.
Publicado: (2021)

The productivity gains associated with a junk food tax and their impact on cost-effectiveness
por: Carter, Hannah E., et al.
Publicado: (2019)

Cost-effectiveness of changes in alcohol taxation in Denmark: a modelling study
por: Holm, Astrid Ledgaard, et al.
Publicado: (2014)

Presence of trans-Fatty Acids Containing Ingredients in Pre-Packaged Foods and the Availability of Reported trans-Fat Levels in Kenya and Nigeria
por: Huang, Liping, et al.
Publicado: (2023)

Estimation and determinants of direct medical costs of ischaemic heart disease, stroke and hypertensive heart disease: evidence from two major hospitals in Cameroon
por: Aminde, Leopold Ndemnge, et al.
Publicado: (2021)

Cost-effectiveness analysis of population salt reduction interventions to prevent cardiovascular disease in Cameroon: mathematical modelling study
por: Aminde, Leopold Ndemnge, et al.
Publicado: (2020)

A cost–benefit analysis of COVID-19 lockdowns in Australia
por: Lally, Martin
Publicado: (2022)

Ruminant and industrially produced trans fatty acids: health aspects
por: Stender, Steen, et al.
Publicado: (2008)

The Impact of a Tax on Sugar-Sweetened Beverages on Health and Health Care Costs: A Modelling Study
por: Veerman, J. Lennert, et al.
Publicado: (2016)

Investment Success in Public Health: An Analysis of the Cost-Effectiveness and Cost-Benefit of the Global Programme to Eliminate Lymphatic Filariasis
por: Turner, Hugo C., et al.
Publicado: (2017)

Industrial Trans Fatty Acid and Serum Cholesterol: The Allowable Dietary Level
por: Takeuchi, Hiroyuki, et al.
Publicado: (2017)

The estimated health impact of sodium reduction through food reformulation in Australia: A modeling study
por: Trieu, Kathy, et al.
Publicado: (2021)

Modelled Cost-Effectiveness of a Package Size Cap and a Kilojoule Reduction Intervention to Reduce Energy Intake from Sugar-Sweetened Beverages in Australia
por: Crino, Michelle, et al.
Publicado: (2017)

Content of industrially produced trans fatty acids in breast milk: An observational study
por: Bousset‐Alféres, Christian Mayela, et al.
Publicado: (2022)

Dietary Ruminant and Industrial Trans-Fatty Acids Intake and Colorectal Cancer Risk
por: Seyyedsalehi, Monireh Sadat, et al.
Publicado: (2022)

Estimating the potential impact of Australia’s reformulation programme on households’ sodium purchases
por: Coyle, Daisy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e5rlfdje94j4v6hpqscr69fcid